Advertisement

Drugs

, Volume 41, Issue 4, pp 533–547 | Cite as

Dissociation Between the Antinociceptive and Anti-Inflammatory Effects of the Nonsteroidal Anti-Inflammatory Drugs

A Survey of Their Analgesic Efficacy
  • Keith McCormack
  • Kay Brune
Review Article

Summary

The authors challenge the general view that the analgesic effect of the nonsteroidal anti-inflammatory drugs (NSAIDs) can be universally attributed to their inhibitory effects on the synthesis of peripherally formed prostaglandins. Analgesic activity by some of these compounds in the reduction of physiological pain elicited by a single noxious stimulus, or the treatment of acute pain which results from sudden trauma to otherwise healthy tissue, is better described as an antinociceptive effect.

Single-dose studies in the dental pain model that have been conducted in double-blind conditions and included a placebo control group have been reviewed; those NSAIDs which are significantly superior to the reference compound aspirin 650mg and those which could represent real alternatives to the use of narcotics in certain situations for the management of acute pain have been identified.

Azapropazone, diflunisal, naproxen, oxaprozin and tolmetin are all weak inhibitors of pros-taglandin synthesis, yet they have been shown to be more effective than aspirin. In a model of joint pain, azapropazone 600mg has been shown to be as effective as pethidine (meperidine) 100mg despite being the weakest inhibitor of prostaglandin synthesis. Whether the antinociceptive effect of azapropazone acts at a peripheral or a central level, or both, is not clear; evidence for the effects of NSAIDs on the central nervous system (CNS) is discussed.

Historically, the antinociceptive character of some NSAIDs is apparent in several studies in both animals and humans. More recently, experimental algesimetry models designed to distinguish the antinociceptive effects of NSAIDs include the use in humans of photoplethysmography and computer-supported infrared thermographic imaging.

Keywords

Antinociceptive Effect Etodolac Tenoxicam Nabumetone Mefenamic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdel-Halim MS, Sjoquist B, Anggard E. Inhibition of prostaglandin synthesis in rat brain. Acta Pharmacologica et Toxicologica 43: 266, 1978PubMedCrossRefGoogle Scholar
  2. Adair SF, Mehlisch DR, Brandes S, Brown P, Burton C. Diclofenac sodium (voltaren) shows analgesic efficacy in dental pain model. Journal of Clinical Pharmacology 28: 915, 1988Google Scholar
  3. Adriaensen H, Gybels J, Handwerker HO, Van Hees J. Nociceptor discharges and sensations due to prolonged noxious mechanical stimulation: a paradox. Human Neurobiology 3: 53–58, 1984PubMedGoogle Scholar
  4. Albengres E, Pinquier JL, Riant P, Urien S, Barre J, et al. Pharmacological criteria for risk-benefit evaluation of NSAIDs. Scandinavian Journal of Rheumatology (Suppl. 73): 3–15, 1988Google Scholar
  5. Balali-Mood M, Critchley JAJH, Proudfoot AT, Prescott LF. Mefenamic acid overdose. Lancet 1: 1354–1356, 1981PubMedCrossRefGoogle Scholar
  6. Beaver WT, Forbes JA, Shackleford RW. A method for the 12-hour evaluation of analgesic efficacy in outpatients with postoperative oral surgery pain, three studies of diflunisal. Pharmacotherapy 3: 23S–37S, 1983PubMedGoogle Scholar
  7. Bensemana D, Gascon AL. Relationship between analgesia and turnover of brain biogenic amines. Canadian Journal of Physiology and Pharmacology 56: 721–730, 1978PubMedCrossRefGoogle Scholar
  8. Bloomfield SS, Mitchell J, Cissell G, Peters N. Time course of NSAID analgesia in 3 pain models. Abstract J-7. Clinical Pharmacology and Therapeutics 45: 176, 1989Google Scholar
  9. Boraks S. Flurbiprofen em dose baixa comparado a dipirona, acido acetilsalicilico e placebo no tratamento da dor pos-extracao dentaria. Arquivos Brasileiros de Medicina 61: 424–430, 1987Google Scholar
  10. Braga PC, Biella G, Tiengo M. Effects of tenoxicam on nociceptive thalmic neuronal firing in arthritic rats. Drugs Under Experimental Clinical Research XIII: 389–398, 1987Google Scholar
  11. Brogden RN. Non-steroidal anti-inflammatory analgesics other than salicylates. Drugs 32 (Suppl. 4): 27–45, 1986PubMedCrossRefGoogle Scholar
  12. Bromm B, Meier W. The intracutaneous stimulus: a new pain model for algesimetric studies. Methods and Findings in Experimental Clinical Pharmacology 6(7): 405–410, 1984Google Scholar
  13. Bromm B, Meier W, Scharein E. Imipramine reduces experimental pain. Pain 25: 245–257, 1986PubMedCrossRefGoogle Scholar
  14. Brown CR, Sevelius H, Wild V. A comparison of single doses of naproxen sodium, morphine sulphate and placebo in patients with postoperative pain. Current Therapeutic Research 35: 511–518, 1984Google Scholar
  15. Brune K. Biodistribution of salicylates: a clue to the understanding of some effects and side effects. Agents and Actions 2 (Suppl.): 163–177, 1974Google Scholar
  16. Brune K. Prostaglandins, inflammation and anti-inflammatory drugs. European Journal of Rheumatology and Inflammation 5: 335–349, 1982PubMedGoogle Scholar
  17. Brune K. Pharmacokinetics of azapropazone in comparison to other NSAIDs. In Rainsford KD (Ed.) Azapropazone: 20 years of clinical use, pp. 53–61, Kluwer Academic Publishers, Lancaster, 1989CrossRefGoogle Scholar
  18. Brune K, Graf P. Non-steroidai anti-inflammatory drugs: influence of extra-cellular pH on biodistribution and pharmacological effects. Biochemical Pharmacology 27: 525–530, 1978PubMedCrossRefGoogle Scholar
  19. Brune K, Gubler H, Schweitzer A. Autoradiographic methods for the evaluation of ulcerogenic effects of anti-inflammatory drugs. Pharmacological Theory 5: 199–209, 1979CrossRefGoogle Scholar
  20. Brune K, Rainsford KD, Wagner K, Peskar BA. Inhibition by anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn-Schmiedeberg’s Archives of Pharmacology 315: 269–276, 1981PubMedCrossRefGoogle Scholar
  21. Brune K, Schweitzer A, Eckert H. Parietal cells of the stomach trap salicylates during absorption. Biochemistry and Pharmacology 26: 1735–1740, 1977CrossRefGoogle Scholar
  22. Brune K, Schweitzer A, Lanz R. Importance of drug biodistribution and metabolism in the development of side-effects by anti-inflammatory/analgesic drugs. Advanced Inflammation Research 6: 9–15, 1984Google Scholar
  23. Chang J, Wigley F, Newcombe D. Neutral protease activation of peritoneal macrophage prostaglandin synthesis. Proceedings of the National Academy of Science (USA) 77: 4736, 1980CrossRefGoogle Scholar
  24. Chen ACN, Chapman CR. Aspirin analgesia evaluated by event-related potentials in man: possible central action in brain. Experimental Brain Research 39: 359–364, 1980CrossRefGoogle Scholar
  25. Chiang ST, Knowles JA, Hubsher JA, Ruelius HW, Walker BR. Effects of food on oxaprozin bioavailability. Journal of Clinical Pharmacology 24: 381–385, 1984PubMedGoogle Scholar
  26. Clark MS, Tomasetti BJ, Mehlisch DR. Diclofenac sodium (Voltaren) shows analgesic efficacy in dental pain model. Journal of Dental Research (Special Issue) 68: 918, 1989Google Scholar
  27. Cook AJ, Woolf CJ, Wal PD, McMahon SB. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 325: 151–153, 1987PubMedCrossRefGoogle Scholar
  28. Cooper SA, Berrie R, Cohn P. Comparison of ketoprofen, ibuprofen and placebo in a dental surgery pain model. Advances in Therapy 5: 43–53, 1988aGoogle Scholar
  29. Cooper SA, Engel J, Ladov M, Precheur H, Rosenheck A, et al. Analgesic efficacy of an ibuprofen-codeine combination. Pharmacotherapy 2: 162–167, 1982aPubMedGoogle Scholar
  30. Cooper SA, Finizio T, Gottlieb S. Analgesic efficacy of tolmetin. Abstract C35. Clinical Pharmacology and Therapeutics 33: 195, 1983bGoogle Scholar
  31. Cooper SA, Gelb SB, Cavaliere MBM, Cohn P, Dyer C. An analgesic relative potency assay comparing ketoprofen and aspirin in postoperative dental pain. Advances in Therapy 1(6): 410–418, 1984Google Scholar
  32. Cooper SA, Gelb S, Goldman EH, Cohn P. Relative analgesic efficacy of zomepirac vs fenoprofen. Abstract B59. Clinical Pharmacology and Therapeutics 33: 194, 1983aGoogle Scholar
  33. Cooper SA, Greene JJ, Schachtel BP, Berrie JJ, Finizio TA, et al. Ibuprofen 400mg (IBU) compared to acetaminophen 600mg with codeine 60mg (APAP/COD). Abstract J-6. Clinical Pharmacology and Therapeutics 45: 176, 1989Google Scholar
  34. Cooper SA, Gross J, Vogel R, Perrie P. Relative analgesic efficacy of ibuprofen and zomepirac in peridontal and oral surgery pain. Abstract C34. Clinical Pharmacology and Therapeutics 33: 194, 1983cGoogle Scholar
  35. Cooper SA, Mardirossian G. Comparison of flurbiprofen and aspirin in the relief of postsurgical pain using the dental pain model. American Journal of Medicine 80 (Suppl. 3A): 36–40, 1986PubMedCrossRefGoogle Scholar
  36. Cooper SA, Mardirossian G, Becker D. Evaluation of the analgesic efficacy of flurbiprofen. Abstract C21. Clinical Pharmacology and Therapeutics 31: 213, 1982bGoogle Scholar
  37. Cooper SA, Mardirossian G, Milles M. Analgesic relative potency assay comparing flurbiprofen 50, 100 and 150mg, aspirin 600mg and placebo in postsurgical dental pain. Clinical Journal of Pain 4: 175–181, 1988bCrossRefGoogle Scholar
  38. Cooper SA, Needle SE, Kruger GO. Comparative analgesic potency of aspirin and ibuprofen. Journal of Oral Surgery 35: 898–903, 1977PubMedGoogle Scholar
  39. Court H, Volans GN. Poisoning after overdose with non-steroidal anti-inflammatory drugs. Adverse Drug Reactions and Acute Poisoning Reviews 3: 1–21, 1984PubMedGoogle Scholar
  40. Crunkhorn P, Willis AL. Cutaneous reactions to intradermal prostaglandins. British Journal of Pharmacology and Chemotherapy 41: 49–56, 1971CrossRefGoogle Scholar
  41. Cullen E. Novel anti-inflammatory agents. Journal of Pharmaceutical Sciences 73: 579–589, 1984PubMedCrossRefGoogle Scholar
  42. Demerson CA, Humber LG, Abraham NA, Schilling G, Martel RR, et al. Resolution of etodolac and anti-inflammatory and prostaglandin synthetase inhibiting properties of the enantiomers. Journal of Medicinal Chemistry 26: 1778–1780, 1983PubMedCrossRefGoogle Scholar
  43. Dupuis R, Lemay H, Bushnell MC, Duncan GH. Preoperative flurbiprofen in oral surgery: a method of choice in controlling postoperative pain. Pharmacotherapy 8: 193–199, 1988PubMedGoogle Scholar
  44. Desjardins PJ, Cooper SA, Foster M, Gallegos T, Allwein J, et al. Efficacy of zomepirac-codeine complications in dental pain. Clinical Pharmacology and Therapeutics 35: 234, 1984Google Scholar
  45. Desjardins PJ, Iranpour B, Handelman S, Emmings P. Piroxicam in dental pain. Abstract 410. Journal of Dental Research (Special Issue) 68: 918, 1989Google Scholar
  46. Dolci G. Actions of naproxen sodium on pulpal pain. XV International Congress on Rheumatology, Paris, June 21–27, 1981 (Therapeutic Sessions), pp. 44-50, Syntex Inc., California, 1982Google Scholar
  47. Douze JCL, Zelvelder WG. A double-blind comparative investigation of the analgesic effect of glafenine. Tijdschrift vor Geneesmiddelen 6: 958–961, 1981Google Scholar
  48. Editorial. NSAIDs for renal and biliary colic: intramuscular diclofenac. Drug and Therapeutics Bulletin 25 (2): 85–86, 1987Google Scholar
  49. Farr M, Hawkins CF, Kendall MJ, Willis JV. Some observations and speculations on the factors influencing the concentration of phenylbutazone in synovial fluid. International Journal of Clinical Pharmacology, Therapy and Toxicology 20: 589–594, 1982Google Scholar
  50. Ferdinandi ES, Cayen MN, Pace-Asciak C. Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats. Journal of Pharmacology and Experimental Therapeutics 220: 417–426, 1982PubMedGoogle Scholar
  51. Ferreira SH. Prostaglandins, aspirin-like drugs and analgesia. Nature: New Biology 240: 200–203, 1972CrossRefGoogle Scholar
  52. Fitzpatrick FA, Wynalda MA. In vivo suppression of prostaglandin biosynthesis by non-steroidal anti-inflammatory agents. Prostaglandins 12: 1037, 1976PubMedCrossRefGoogle Scholar
  53. Fliedner L, Levsky M, Kechejian H. Analgesia with etodolac in oral postsurgical pain. Current Therapeutic Research 36: 33–45, 1984Google Scholar
  54. Flower RJ, Cheung HA, Cushman DW. Quantitative determination of prostaglandins and malondialdehyde formed by the arachidonate oxygenase (prostaglandin synthetase) system of bovine seminal vesicles. Prostaglandins 4: 325, 1973PubMedCrossRefGoogle Scholar
  55. Forbes JA, Barkaszi BA, Ragland RN, Hankie JJ. Analgesic effect of fendosal, ibuprofen and aspirin in postoperative oral surgery pain. Pharmacotherapy 4: 385–391, 1984PubMedGoogle Scholar
  56. Forbes JA, Beaver WT, Barkaszi BA, Jones KF, Ragland RN, et al. Two clinical evaluations of the analgesic efficacy of sulindac and aspirin in post-operative oral surgery pain. Abstract C40. Clinical Pharmacology and Therapeutics 33: 193, 1983bCrossRefGoogle Scholar
  57. Forbes JA, Beaver WT, Jones KF, Kehm CK. An evaluation of ibuprofen and ibuprofen-caffeine combinations in postoperative oral surgery pain. Clinical Pharmacology and Therapeutics 41: 161, 1987Google Scholar
  58. Forbes JA, Beaver WT, Yorio CC, Selinger LR, Rosenmertz SK. The analgesic efficacy of flurbiprofen, acetylsalicylic acid and placebo in postoperative oral surgery pain. Clinical Pharmacology and Therapeutics 33: 196, 1983cGoogle Scholar
  59. Forbes JA, Butterworth GA, Burchfield WH, Beaver WT, Shackleford RW. A 12-hour evaluation of the analgesic efficacy of diflunisal, zomepirac sodium, aspirin and placebo in postoperative oral surgery pain. Pharmacotherapy 3: 38S–46S, 1983aPubMedGoogle Scholar
  60. Forbes JA, Calderazzo JP, Bowser MW, Foor VM, Shackleford RW, et al. A twelve-hour evaluation of the analgesic efficacy of diflunisal, apropoxyphene, a combination of propoxyphene with acetaminophen and placebo in pain after oral surgery. Clinical Pharmacology and Therapeutics 29: 245, 1981Google Scholar
  61. Forbes JA, Calderazzo JP, Bowser MW, Foor VM, Shackleford RW, et al. A 12-hour evaluation of the analgesic efficacy of diflunisal, aspirin and placebo in postoperative dental pain. Journal of Clinical Pharmacology 22: 89–96, 1982bPubMedGoogle Scholar
  62. Forbes JA, Calderazzo JP, Bowser MW, Foor VM, Shrewsbury W. A 12-hour evaluation of the analgesic efficacy of diflunisal, aspirin and placebo in pain after oral surgery. Clinical Pharmacology and Therapeutics 25: 225, 1979Google Scholar
  63. Forbes JA, Foor VM, Bowser MW, Calderazzo JP, Shackleford RW, et al. A 12-hour evaluation of the analgesic efficacy of diflunisal, propoxyphene, a propoxyphene-acetaminophen combination and placebo in postoperative oral surgery pain. Pharmacotherapy 2: 43–49, 1982aGoogle Scholar
  64. Forbes JA, Keller CK, Smith JW, Zeleznock JR, Sevelius H, et al. Analgesic effect of naproxen sodium, codeine, a naproxencodeine combination and aspirin on the postoperative pain of oral surgery. Pharmacotherapy 6: 211–218, 1986PubMedGoogle Scholar
  65. Forbes JA, Kilgore CK, Smith JW, Zeleznock JR, Beaver WT. A twelve-hour evaluation of the analgesic efficacy of naproxen sodium, codeine, a combination of naproxen sodium with codeine, an aspirin standard and placebo in pain following oral surgery. Abstract C31. Clinical Pharmacology and Therapeutics 31: 226, 1982cGoogle Scholar
  66. Forbes JA, Yorio CC, Selinger LR, Rosenmertz SK, Beaver WT. An evaluation of flurbiprofen, aspirin and placebo in postoperative oral surgery pain. Pharmacotherapy 9: 66–73, 1989PubMedGoogle Scholar
  67. Frame JW, Rout PGJ. A comparison of the analgesic efficacy of flurbiprofen diclofenac, dihydrocodeine/paracetamol and placebo following oral surgery. British Journal of Clinical Practice 40: 463–467, 1986PubMedGoogle Scholar
  68. Frame JW, Rout PGJ. A comparison of ibuprofen and dihydrocodeine in relieving pain following wisdom teeth removal. British Journal of Dentistry 166: 121–124, 1989CrossRefGoogle Scholar
  69. Freeman AM, Undre NA, Thawley AR, Golding DN. Plasma and synovial fluid concentrations of nabumetone and BRL 10720 in patients given nabumetone. Royal Society of Medicine International Congress and Symposium Series 69: 37–42, 1985Google Scholar
  70. Garcia-Rafanell J, Forn J. Correlation between anti-inflammatory activity and inhibition of prostaglandin biosynthesis induced by various non-steroidal anti-inflammatory agents. Drugs Research 29: 630–633, 1979Google Scholar
  71. Gaston GW, Mallow RD, Frank JE. The efficacy of etodolac for patients with pain following oral surgery. Journal of Oral and Maxillofacial Surgery 42: 362–366, 1984PubMedCrossRefGoogle Scholar
  72. Gaucher A, Netter P, Faure G, Schoeller JP, Gerardin A. Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage and cerebrospinal fluid. European Journal of Clinical Pharmacology 25: 107–112, 1983PubMedCrossRefGoogle Scholar
  73. Geiger UP, Degen PH, Sioufi A. Quantitative assay of diclofenac in biological material by gas-liquid chromatography. Journal of Chromatography 111: 293–298, 1975PubMedCrossRefGoogle Scholar
  74. Groppetti A, Braga PC, Biella G, Parenti M, Rusconi L, et al. Effect of aspirin on serotonin and met-enkephalin in brain: correlation with the antinociceptive activity of the drug. Neuropharmacology 27: 499–505, 1988PubMedCrossRefGoogle Scholar
  75. Guedes MS. Analgesic activity of fenbufen in dental pain: comparison with aspirin, codeine, propoxyphene and placebo. A Fohla Medica 71: 593–596, 1975Google Scholar
  76. Handwerker HO, Beck A, Forster C, Gall Th, Magert W. Analgesic effects of dipyrone as compared to placebo. In Brune K (Ed.) New pharmacological and epidemiological data in analgesics research, pp. 19–28, Birkhauser, 1990Google Scholar
  77. He X, Neugebauer V, Schaible HG, Schmidt RF. New aspects of the mode of action of dipyrone. In Brune K (Ed.) New pharmacological and epidemiological data in analgesics research, pp. 9–18, Birkhauser, 1990Google Scholar
  78. Henrikson P, Thilander H, Wahlander LA. Absorption and effect of diclofenac sodium after surgical removal of a lower wisdom tooth. Current Therapeutic Research 31: 20–26, 1982Google Scholar
  79. Horton EW. Action of PGE1 on tissues which respond to brady-kinin. Nature 200: 892, 1963PubMedCrossRefGoogle Scholar
  80. Hunskaar S. Similar effects of acetylsalicylic acid and morphine on immediate responses to acute noxious stimulation. Pharmacology and Toxicology 60: 167–170, 1987PubMedCrossRefGoogle Scholar
  81. Hunskaar S, Berge O, Hole K. Dissociation between antinociceptiv and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test. Pain 25: 125–132, 1986PubMedCrossRefGoogle Scholar
  82. Hunskaar S, Fasmer OB, Hole K. Acetylsalicylic acid, paracetamol and morphine inhibit behavioural responses to intrathecally administered substance P or capsaicin. Life Sciences 37: 1835–1841, 1985PubMedCrossRefGoogle Scholar
  83. Hutton CE. The effectiveness of 100 and 200mg etodolac (Ultradol), aspirin and placebo in patients with pain following oral surgery. Oral Surgery, Oral Medicine, Oral Pathology 56: 575–580, 1983CrossRefGoogle Scholar
  84. Ito R, Suga T, Kawamura H, Shimura M, Saiki T, et al. Pharmacology of azapropazone, a new anti-inflammatory agent. Journal of the Medical Society of Toho University 19: 242–261, 1972Google Scholar
  85. Jahn U, Adrian RW. Pharmakogogische und toxikologische prufung des neuen antiphlogistikums azapropazon/3-dimethylamino-7-methyl-l, 2-(n-propylmalonyl)-l, 2-dihydro-l,2,4-benzotriazin. Arzneimittel-Forschung 19: 36, 1969PubMedGoogle Scholar
  86. Jahn U, Wagner-Jauregg T. Verleich von zwei neunen klassen antiphlogistischer Substanzen im collier-test. Arzneimittel-Forschung 18: 20, 1968Google Scholar
  87. Jahn U, Wagner-Jauregg T. Wirkungsvergleich saurer antiphlogistika im bradykinin, UV-erythem und rattenpfotenodem-test. Arzneimittel-Forschung 24: 494, 1974PubMedGoogle Scholar
  88. Jahnchen E, Blanck KJ, Breuing KH, Gilfrich HJ, Meinertz T, et al. Plasma protein binding of azapropazone in patients with kidney and liver disease. British Journal of Clinical Pharmacology 11: 361–367, 1981PubMedCrossRefGoogle Scholar
  89. John VA. The pharmacokinetics and metabolism of diclofenac sodium (Voltarol) in animals and man. Rheumatology and Rehabilitation (Suppl. 2): 22–35, 1979Google Scholar
  90. Juhlin S, Michaelsson G. Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopic dermatitis. Acta Dermato-Venereologica 49: 251–261, 1969PubMedGoogle Scholar
  91. Karim S. Action of prostaglandin in the pregnant woman. Annals of the New York Academy of Sciences 180: 483–498, 1971PubMedCrossRefGoogle Scholar
  92. Kusner G, Reader A, Beck FM, et al. A study comparing the effectiveness of ibuprofen (Motrin), Empirin with Codeine no. 3, and Synalgos-DC for the relief of postendodontic pain. Journal of Endodontics 10: 210–214, 1984PubMedCrossRefGoogle Scholar
  93. Levine JD, Taiwo YO, Collins SD, Tarn JK. Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature 323: 158–161, 1986PubMedCrossRefGoogle Scholar
  94. Lewis AJ. The pharmacological profile of oxaprozin. Seminars in Arthritis and Rheumatism 15 (Suppl. 2): 11–17, 1986CrossRefGoogle Scholar
  95. Lobo R, Gallardo F, Henriquez E, Iriarte E. Analgesic activity of ketoprofen in post-operative oral surgery pain. IRCS Medical Science 11: 639–640, 1983Google Scholar
  96. Lundstam SOA, Leissner K, Wahlander LA, Krai JG. Prostaglandin-synthetase inhibition with diclofenac sodium in treatment of renal colic: comparison with use of a narcotic analgesic. Lancet 1: 1096–1097, 1982PubMedCrossRefGoogle Scholar
  97. Maggon KK, Lam GM. Aspects of clinical pharmacology and bio-availability of azapropazone. In Rainsford KD (Ed.) Azapropazone: 20 years of clinical use, pp. 123–150, Kluwer Academic Publishers, Lancaster, 1989CrossRefGoogle Scholar
  98. Mangan FR, Flack JD, Jackson D. Preclinical overview of nabumetone. American Journal of Medicine 83 (Suppl. 4B): 6–10, 1987PubMedCrossRefGoogle Scholar
  99. Marchettini P, Lacerenza M, Ieracitano D, Canal N. Sensitized nociceptors in reflex sympathetic dystrophies. Functional Neurology 4: 135–140, 1989PubMedGoogle Scholar
  100. Mardirossian G, Cooper SA. Comparison of the analgesic efficacy of flurbiprofen and aspirin for postsurgical dental pain. Journal of Oral and Maxillofacial Surgery 43: 106–109, 1985PubMedCrossRefGoogle Scholar
  101. Marquez JO, Ferreira SH. Regional dipyrone nociceptor blockade: a pilot study. Brazilian Journal of Medical Biological Research 20: 441–444, 1987Google Scholar
  102. Matthews B, Searle BN. Electrical stimulation of teeth. Pain 2: 245–251, 1976PubMedCrossRefGoogle Scholar
  103. McCormack K. Mathematical model for assessing risk of gastrointestinal reactions to NSAIDs. In Rainsford KD (Ed.) Azapropazone: 20 years of clinical use, pp. 81–93, Kluwer Academic Publishers, Lancaster, 1989CrossRefGoogle Scholar
  104. McCormack K, Brune K. Classical absorption theory and the development of gastric mucosal damage associated with the nonsteroidal anti-inflammatory drugs. Archives of Toxicology 60: 261–269, 1987PubMedCrossRefGoogle Scholar
  105. McCormack K, Brune K. The amphiprotic character of azapropazone and its relevance to the gastric mucosa. Archives of Toxicology 64: 1–6, 1990PubMedCrossRefGoogle Scholar
  106. Mehlisch D, Frakes L, Cavaliere MB, Gelman M. Double-blind parallel comparison of single oral doses of ketoprofen, codeine and placebo in patients with moderate to severe dental pain. Journal of Clinical Pharmacology 24: 486–492, 1984PubMedGoogle Scholar
  107. Melzack R, Bentley KC, Jeans ME. Piroxicam versus acetaminophen and placebo for the relief of postoperative dental pain. Current Therapeutic Research 37: 1134–1140, 1985Google Scholar
  108. Menetrey D, Chaouch A, Besson JM. Responses of spinal cord dorsal horn neurones to non-noxious and noxious cutaneous temperature changes in the spinal rat. Pain 6: 265–282, 1979PubMedCrossRefGoogle Scholar
  109. Morse DR, Furst ML, Koren LZ, Bolanos OR, Esposito JV, et al. Comparison of diflunisal and an aspirin-codeine combination in the management of patients having one-visit endodontic therapy. Clinical Therapeutics 9: 5, 1987Google Scholar
  110. Moskowitz MA, Buzzi MG, Sakas DE, Linnik MD. Pain mechanisms underlying vascular headaches. Revue Neurologique (Paris) 145(3): 181–193, 1989Google Scholar
  111. Murase K, Randic M. Actions of substance P on rat spinal dorsal horn neurones. Journal of Physiology 346: 203–217, 1984PubMedGoogle Scholar
  112. Nathan PW. The sympathetic system and pain. Functional Neurology 4: 11–15, 1989PubMedGoogle Scholar
  113. Negm MM. Management of endodontic pain with nonsteroidal anti-inflammatory agents: a double-blind, placebo-controlled study. Oral Surgery 67: 88–95, 1989CrossRefGoogle Scholar
  114. Nelson SL, Adair SF, Brahim JS. Dental pain trial measures analgesia of diclofenac sodium. Journal of Dental Research (Special Issue) 68: 224, 1989Google Scholar
  115. Nelson SL, Bergman SA. Relief of dental surgery pain: a controlled 12-hour comparison of etodolac, aspirin and placebo. Anesthesia Progress July/August 1985: 151–156, 1985Google Scholar
  116. Nelson SL, Brahim J, Treglown S. Double-blind study of piroxicam (2 doses), aspirin and placebo in patients with postoperative dental pain. Abstract 7. Clinical Pharmacology and Therapeutics 41: 182, 1987Google Scholar
  117. Nishimura M, Awano H, Yagasaki O. Sodium salicylate facilitates calcium-dependent release of transmitter at mouse neuromuscular junctions. British Journal of Pharmacology 97: 1239–1245, 1989PubMedCrossRefGoogle Scholar
  118. Nystrom E, Gustafsson I, Quiding H. The pain intensity at analgesic intake, and the efficacy of diflunisal in single doses and effervescent acetaminophen in single and repeated doses. Pharmacotherapy 8: 201–209, 1988PubMedGoogle Scholar
  119. Ohnishi M, Kawai T, Ogawa N. Double-blind evaluation of piroxicam and indomethacin in the treatment of inflammation following oral surgery. European Journal of Rheumatic Inflammation 6: 259–265, 1983Google Scholar
  120. Olson N, Sunshine A, Marerro I, Ramos I, Juan E. Piroxicam, aspirin and placebo in dental pain. Clinical Pharmacology and Therapeutics 41: 162, 1987Google Scholar
  121. Pelissier T, Bustos E, Paeile C. Effects of the anti-inflammatory drug mefenamic acid on the electrophysiologic activity of some cerebral structures. Research Communications in Psychology, Psychiatry and Behaviour 9: 221–226, 1984Google Scholar
  122. Price DD, Hu JW, Dubner R, Gracely RH. Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain 3: 57–68, 1977PubMedCrossRefGoogle Scholar
  123. Quilez C, Perez-Mateo M, et al. The value of diclofenac-sodium, a non-steroidal anti-inflammatory, in the treatment of renal colic: comparative study with a spasmolytic and an opiate. Medical Clinic (Barcelona) 82: 754–755, 1984Google Scholar
  124. Rainsford KD. Side-effects of anti-inflammatory/analgesic drugs: epidemiology and gastrointestinal tract. Trends in Pharmacologica Sciences 5: 156–159, 1984CrossRefGoogle Scholar
  125. Rainsford KD. The mode of action of azapropazone in relation to its therapeutic actions in rheumatic conditions and its major side-effects. In Rainsford KD (Ed.) Azapropazone: 20 years of clinical use, pp. 31–52, Kluwer Academic Publishers, Lancaster, 1989aCrossRefGoogle Scholar
  126. Rainsford KD. Epilogue, with some thoughts for research on azapropazone. In Rainsford KD (Ed.) Azapropazone: 20 years of clinical use, pp. 281–289, Kluwer Academic Publishers, Lancaster, 1989bCrossRefGoogle Scholar
  127. Rees MCP, Canete-Soler R, Bernai AL, Turnbull AC. Effect of fenamates on prostaglandin receptor binding. Lancet 2: 541–542, 1988PubMedCrossRefGoogle Scholar
  128. Ruedy J. A comparison of the analgesic efficacy of naproxen and acetylsalicylic acid-codeine in patients with pain after dental surgery. Scandinavian Journal of Rheumatology (Suppl. 2): 60–63, 1973Google Scholar
  129. Robson RH, Balali M, Critchley J, Proudfoot AT, Prescott L. Mefenamic acid poisoning and epilepsy. British Medical Journal 2: 1438, 1979PubMedCrossRefGoogle Scholar
  130. Rodrigo MRC, Rosenquist JB, Cheung LK. Paracetamol and diflunisal for pain relief following third molar surgery in Hong Kong Chinese. International Journal of Oral Maxillofacial Surgery 16: 566–571, 1987CrossRefGoogle Scholar
  131. Rondeau PL, Yeung E, Nelson P. Dental surgery pain: analgesic. Journal of the Canadian Dental Association 7: 433–439, 1980Google Scholar
  132. Rowe NH, Cudmore CL, Turner JL. Control of pain by mefenamic acid following removal of impacted molar. Oral Surgery 51: 575–580, 1981CrossRefGoogle Scholar
  133. Rowe NH, Shekter MA, Turner JL, Spencer J, Dowson J, et al. Control of pain resulting from endodontic therapy: a double-blind, placebo-controlled study. Oral Surgery 50: 257–263, 1980CrossRefGoogle Scholar
  134. Schweitzer A, Brune K. Salicylic acid and proquazone: the differences in absorption and biodistribution explain their different profile of side-effects. In Willoughby DA et al. (Eds) Perspectives in inflammation, MTP Press, UK, pp. 353–360, 1977Google Scholar
  135. Scott D. Aspirin: action on receptor in the tooth. Science 161: 180–181, 1968PubMedCrossRefGoogle Scholar
  136. Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin test: characteristic biphasic pain response. Pain 38: 347–352, 1989PubMedCrossRefGoogle Scholar
  137. Shimura K. Clinical effects of azapropazone in the field of oral surgery. Kiso to Rinsho 6: 2339–2349, 1972Google Scholar
  138. Shipton EA, Muller FO. Severe mefenamic acid poisoning: a case report. South African Medical Journal 67: 823–824, 1985PubMedGoogle Scholar
  139. Spring H, Heidecker JL, Wright A, Davies I ab I, Walker FS, et al. Analgesic effects of azapropazone. In Rainsford KD (Ed.) Azapropazone: 20 years of clinical use, pp. 185–201, Kluwer Academic Publishers, Lancaster, 1989CrossRefGoogle Scholar
  140. Steinhauer HB, Hertting G. Lowering of the convulsive threshold by non-steroidal anti-inflammatory drugs. European Journal of Pharmacology 69: 199, 1981PubMedCrossRefGoogle Scholar
  141. Steinhauser E. Anwendung von ponstan bei schmerz und entzundungszustanden nach zahnarztlich-chirurgischen eingriffen. SMfZ/RMSO 80: 341–350, 1970Google Scholar
  142. Sunshine A, Manrero I, McCormick N, Lawrence V, Gaffney M, et al. The analgesic efficacy of piroxicam, aspirin and placebo in postoperative oral surgery pain. Clinical Pharmacology and Therapeutics 37: 232, 1985Google Scholar
  143. Taiwo YO, Bjerknes LK, Goetzl EJ, Levine JD. Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience 32: 577–580, 1989PubMedCrossRefGoogle Scholar
  144. Todd PA, Brogden RN. Oxaproxin: a preliminary review of its pharmacokinetic properties and therapeutic efficacy. Drugs 32: 291–312, 1986PubMedCrossRefGoogle Scholar
  145. Togl-Leimuller A, Egger G, Porta S. Albumin as one-way transport vehicle into sites of inflammation. Experimental Pathology 30: 91–96, 1986PubMedCrossRefGoogle Scholar
  146. Urien S, Albengres E, Pinquier JL, Tillement JP. Role of alpha1 acid glycoprotein, albumin and nonesterified fatty acids in serum binding of apazone and warfarin. Clinical Pharmacology and Therapeutics 39: 683–689, 1986PubMedCrossRefGoogle Scholar
  147. Vale JA, Meredith TJ. Acute poisoning due to non-steroidal antiinflammatory drugs. Medical Toxicology 1: 12–31, 1986PubMedGoogle Scholar
  148. Wall PD. The prevention of postoperative pain. Pain 33: 289–290, 1988PubMedCrossRefGoogle Scholar
  149. Wall PD, Woolf CJ. Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. Journal of Physiology 356: 443–458, 1984PubMedGoogle Scholar
  150. Wallenstein MC. Differential effects of prostaglandin synthetase inhibitors on EEG in rat. European Journal of Pharmacology 111: 201–209, 1985PubMedCrossRefGoogle Scholar
  151. Walton G. A comparison of ibuprofen and an ibuprofen-codeine combination in the relief of post-operative oral surgery pain. Abstract 170. Journal of Dental Research April: 580, 1989Google Scholar
  152. Wanwimolruk S, Brooks PM, Birkett DJ. Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients. British Journal of Clinical Pharmacology 15: 91–94, 1983PubMedCrossRefGoogle Scholar
  153. Wennmalm A, Carlsson I, Edlund A, Eriksson S, Kaijser L, et al. Central and peripheral haemodynamic effects of non-steroidal anti-inflammatory drugs in man. Archives of Toxicology (Suppl. 7): 350–359, 1984Google Scholar
  154. Willer JC, Harreyn JM. Effet inhibiteur central du ketoprofene intraveineux sur le reflexe nociceptif de flexion chez Fhomme. Presse Medicale 16: 63–67, 1987Google Scholar
  155. Willis AL. Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion. Journal of Pharmacy and Pharmacology 21: 216–218, 1969CrossRefGoogle Scholar
  156. Willis JV, Kendall MJ, Jack DB. The influence of food on the absorption of diclofenac after single and multiple oral doses. European Journal of Clinical Pharmacology 19: 33–37, 1981PubMedCrossRefGoogle Scholar
  157. Winter L, Bass E, Recant B, Cahaly JF. Analgesic activity of ibuprofen (Motrin) in postoperative oral surgical pain. Oral Surgery 45: 159–166, 1978CrossRefGoogle Scholar
  158. Winter Jr L, Post A. Double-blind comparison of single oral doses of oxaprozin, aspirin and placebo for relief of post-operative oral surgery pain. Journal of International Medical Research 11: 308–314, 1983PubMedGoogle Scholar
  159. Woolf CJ. Central and peripheral components of the hyperalgesia that follows peripheral tissue injury. In Rowe M & Willis WD (Eds) Development, organization and processing in somato-sensory pathways, pp. 317–323, Alan R. Liss Inc. New York, 1985Google Scholar
  160. Woolf CJ. Physiological, inflammatory and neuropathic pain. Advances and Technical Standards in Neurosurgery 15: 39–62, 1987PubMedCrossRefGoogle Scholar
  161. Woolf CJ. Recent advances in the pathophysiology of acute pain. British Journal of Anaesthesia 63: 139–146, 1989PubMedCrossRefGoogle Scholar
  162. Woolf CJ, King AE. Sublimai fringes and the plasticity of dorsal horn neurons’ receptive field properties. Abstract 279.22. British Journal of Anaesthesia 14: 696, 1988Google Scholar
  163. Woolf CJ, Wiesenfeld-Hallin Z. Substance P and calcitonin gene-related peptide synergistically modulate the gain of the nociceptive flexor withdrawal reflex in the rat. Neuroscience Letters 66: 226–230, 1986PubMedCrossRefGoogle Scholar
  164. Wright A, Davies I ab I. The recording of brain evoked potentials resulting from intra-articular focused ultrasonic stimulation: a new experimental model for investigating joint pain in humans. Neuroscience Letters 97: 145–150, 1989PubMedCrossRefGoogle Scholar
  165. Wright A, Davies I ab I, Walker FS, Riddell JG. Azapropazone analgesia in a joint pain model. Abstract 93. British Journal of Rheumatology 28: 53, 1989CrossRefGoogle Scholar
  166. Young RJ. Mefenamic acid poisoning and epilepsy. British Medical Journal 2: 672, 1979PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1991

Authors and Affiliations

  • Keith McCormack
    • 1
    • 2
  • Kay Brune
    • 1
    • 2
  1. 1.McCormack LimitedEngland
  2. 2.Institut fur Pharmakologie und ToxikologieUniversitat Erlangen-NurnbergErlangenGermany

Personalised recommendations